PYRAZOLE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS

摘要

A compound represented by the formula (I) (wherein R1, R2, R3 and R4 are as defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.